3rd Quarter - Report

W STRATEGIES, LLC for GILEAD SCIENCES, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S.4348: FDASLA Act of 2022 and H.R.7667: Food and Drug Amendments of 2022.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: S. 4348 (117th), H.R. 7667 (117th)

Medicare/Medicaid MMM

H.R.5376 - Inflation Reduction Act of 2022.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5376 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.